07:50 AMKimberly-Clark (KMB): Q3 EPS of $1.40 beats by $0.27. Revenue of $4.91B (-1.7%) in-line. Sees full-year EPS of $4.50-$4.60 vs. consensus of $4.26, citing increased cost savings, better organic sales growth and a further recovery in currency exchange rates. Shares +5.5% premarket. (PR)
Comment!
11:45 AM
Sales of products driven by the H1N1 flu pandemic - sanitizers, cleansers and face masks - are brisk and are likely to drive profits in the short term for makers such as Clorox (CLX), Ecolab (ECL) and Kimberly-Clark (KMB), though the boost likely won't be long-lasting.
Comment!
Friday, October 9, 2009
08:48 AM
Kimberly-Clark (KMB) will pay $324M in cash to buy I-Flow (IFLO), a maker of low-cost drug delivery systems and products for post-surgical pain relief and surgical site care. The $12.65/share offer is an 8% premium to Thursday's close (PR). KMB -0.7% premarket. IFLO +7.1%.
Comment!
Thursday, July 23, 2009
07:53 AMKimberly-Clark (KMB): Q2 EPS of $1.16 beats by $0.22. Revenue of $4.7B (-5.6%) vs. $4.6B. Issues upside FY '09 EPS guidance of $4.10-4.25 vs. $4.12 consensus. (PR)
Comment!
08:56 AM
Kimberly-Clark (KMB) to cut 1,600 jobs in an effort to save $150M/year. Expects to save $0.10/share in H2.
Comment!
Wednesday, April 22, 2009
07:56 AMKimberly-Clark (KMB): Q1 EPS of $0.98 beats by $0.01. Revenue of $4.49B (-6.6%) in-line. Sees full-year EPS of $4.00-$4.20 vs. $4.14. "While we are encouraged that commodity costs have declined and have begun to positively impact our gross margins, economic weakness is impacting demand for our products." (PR)
Comment!
15:32 PMDesigning the iPhone of diapers: "The average person thinks of a diaper and thinks, What else can you do to it?" Kimberly-Clark's (KMB) proving you can do a lot.
Comment!